Related Experiment Video
Updated: Dec 10, 2025

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Reovirus σ3 Protein Limits Interferon Expression and Cell Death Induction
Katherine E Roebke1, Yingying Guo2, John S L Parker2
1Department of Biology, Indiana University, Bloomington, Indiana, USA.
Abstract:
Induction of necroptosis by mammalian reovirus requires both type I interferon (IFN)-signaling and viral replication events that lead to production of progeny genomic double-stranded RNA (dsRNA). The reovirus outer capsid protein μ1 negatively regulates reovirus-induced necroptosis by limiting RNA synthesis. To determine if the outer capsid protein σ3, which interacts with μ1, also functions in regulating necroptosis, we used small interfering RNA (siRNA)-mediated knockdown. Similarly to what was observed in diminishment of μ1 expression, knockdown of newly synthesized σ3 enhances necroptosis. Knockdown of σ3 does not impact reovirus RNA synthesis. Instead, this increase in necroptosis following σ3 knockdown is accompanied by an increase in IFN production. Furthermore, ectopic expression of σ3 is sufficient to block IFN expression following infection. Surprisingly, the capacity of σ3 protein to bind dsRNA does not impact its capacity to diminish production of IFN. Consistent with this, infection with a virus harboring a mutation in the dsRNA binding domain of σ3 does not result in enhanced production of IFN or necroptosis. Together, these data suggest that σ3 limits the production of IFN to control innate immune signaling and necroptosis following infection through a mechanism that is independent of its dsRNA binding capacity.IMPORTANCE We use mammalian reovirus as a model to study how virus infection modulates innate immune signaling and cell death induction. Here, we sought to determine how viral factors regulate these processes. Our work highlights a previously unknown role for the reovirus outer capsid protein σ3 in limiting the induction of a necrotic form of cell death called necroptosis. Induction of cell death by necroptosis requires production of interferon. The σ3 protein limits the induction of necroptosis by preventing excessive production of interferon following infection.
Insights
Mammalian reovirus outer capsid protein σ3 limits necroptosis by controlling interferon production. Knockdown of σ3 enhances necroptosis and interferon levels, independent of dsRNA binding.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Mammalian reovirus induces necroptosis, a form of programmed cell death.
- This process requires type I interferon (IFN) signaling and viral replication.
- Reovirus outer capsid protein μ1 negatively regulates necroptosis by limiting RNA synthesis.
Purpose of the Study:
- To investigate the role of reovirus outer capsid protein σ3 in regulating necroptosis.
- To determine if σ3 influences IFN production and innate immune signaling.
Main Methods:
- Small interfering RNA (siRNA)-mediated knockdown of σ3 expression.
- Assessment of necroptosis induction.
- Measurement of viral RNA synthesis.
- Quantification of IFN production.
- Ectopic expression of σ3.
- Analysis of a mutant virus lacking dsRNA binding capacity in σ3.
Main Results:
- Knockdown of σ3 enhanced necroptosis, similar to μ1 knockdown.
- σ3 knockdown increased IFN production without affecting viral RNA synthesis.
- Ectopic expression of σ3 suppressed IFN production post-infection.
- σ3's ability to diminish IFN production was independent of its dsRNA binding capacity.
Conclusions:
- Reovirus σ3 protein limits IFN production to control innate immune signaling and necroptosis.
- This regulation occurs through a mechanism independent of σ3's dsRNA binding ability.
- σ3 plays a novel role in preventing excessive IFN induction and subsequent necroptosis during reovirus infection.
Related Concept Videos
Leaky Scanning
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

